Congratulations to Professor Nir Friedman on receiving the prestigious ERC Proof of Concept grant!
His research integrates computational methods with hands-on lab work, focusing on the diagnosis of autoimmune hepatitis using liquid biopsies. Discover more about Professor Friedman’s lab and publications: To Friedman Lab
Congratulations to Prof. Michal Baniyash, Hadas Preiser, and Or Reuven on their recent paper published in Cancer Research Communications!
In the paper, The researchers present an illustrative model that unveils the pivotal role of MDSC-microbiota crosstalk in developing Colitis-Associated Cancer (CAC). Attached is the abstract: The intricate interplay of genetic and environmental factors can trigger chronic intestinal inflammation, accompanied by dysbiosis, and the activation and recruitment of Myeloid-Derived Suppressor Cells (MDSCs). This process results […]
Memorial Day for the Fallen Soldiers of the Wars of Israel and Victims of Actions of Terrorism 2024
With great sadness, the Lautenberg Center announces the passing of the generous donor Dana Schwartz
Eitan Yefenof wrote a few words on behalf of her memorial: “Dana Schwartz was a torch of love and affection for many circles of people who had the privilege of knowing her. She was also a dear personal friend. Condolences to the Schwartz family, the Concern Foundation family, and the many cancer scientists who benefited […]
Prof. Eli Pikarsky, Prof. Michal Baniyash, Dr. Oren Parnas and Dr. Micha Berger will be receiving the Personalized Medicine research grant!
Read more
Prof. Rami Aqeilan has been elected to serve as the next head of the Institute for Medical Research Israel-Canada (IMRIC) Chairperson.
Studying SARS-CoV-2 at the Lautenberg Center
Dr. Oren Parnas and Dr. Yotam Drier collaborate and use their labs’ resources and advanced techniques to study the coronavirus tissue distribution during infection period, and to study the regulation of the human receptor that allows viral entry to cells. These may lead to novel detection and treatment approaches against SARS-CoV-2.
The Aqeilan’s laboratory won the prestigious proof-of-concept ERC (PoC-ERC) grant to develop a cure for WOREE syndrome.
PoC-ERC grant to Prof. Aqeilan
Prof. Dana Wolf and Dr. Yotam Drier have led efforts to test and implement simple and sensitive pooling approaches to increase the efficiency of clinical testing for SAR-CoV-2.
Thanks to these efforts the throughput of tests of asymptomatic populations at the Hadassah Medical Center increased more than 7-fold, allowing efficient screening of healthcare personnel and nursing homes. This approach can be easily implemented in other clinical labs and drew worldwide attention. Read more
Congratulations to Prof. Ofer Mandelboim and Dr. Pini Tsukerman as their company Nectin Therapeutics secured $6 million in a financing round led by aMoon venture capital fund.
The company raised over $15M in the financing round pending milestones achievement. Read more